BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Amniocentesis
,
Fluoxetine
,
rs7903146
,
PRKCA
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
akt inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
PDK1 null and Akt inhibitor treated cytotoxic T-lymphocyte expression data
CD8-positive melanoma-infiltrating lymphocytes treated with AKT inhibitor VIII (AKTi-1-2)
Breast adenocarcinoma MCF7 and colon carcinoma HCT116 cells treated w/ small molecule AKT inhibitor
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer.
Selectivity Studies and Free Energy Calculations of AKT Inhibitors.
Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical…
An updated patent review of AKT inhibitors (2020 - present).
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Ca…
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Remov…
Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ